FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to oncology, and deals with application of SNS-595 for treatment of subject with cancer, with reduced BRCA2 activity. For this purpose SNS-595 is introduced in therapeutically effective quantity.
EFFECT: effective treatment of cancer is provided due to high sensitivity of mutant BRCA2 cells to introduced preparation.
27 cl, 10 dwg, 6 ex
| Title |
Year |
Author |
Number |
| METHOD OF OBTAINING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID |
2009 |
- Sudkhakar Anantkha
- Subramani Tamilarasan
- Rakhuman Mokhamed Sheik Mokhamed Mudzhibur
- Subbiakh Ramar
|
RU2548031C2 |
| METHODS OF APPLYING (+)-1,4-DIHYDRO-7-[(3S, 4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(THIAZOLYL)-1,8-NAPHTHIRIDINE-3-CARBOXYLIC ACID FOR CANCER TREATMENT |
2006 |
- Ejdelman Deniel S.
- Silverman Dzheffri A.
- Arkin Majkl
- Khajd Dzhennifer
- Uolker Dunkan
- Rajt Zhasmin
|
RU2592231C2 |
| METHODS OF APPLYING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THUASOLYL)-1,8-NAPHTHYDIRINE-3-CARBOXYLIC ACID FOR TREATMENT OF CANCER |
2006 |
- Ehjdelman Dehniel S.
- Silverman Dzheffri A.
- Arkin Majkl
- Khajd Dzhennifer
- Uolker Dunkan
- Rajt Zhasmin
|
RU2428983C2 |
| PHARMACEUTICAL COMBINATION CONTAINING TNO155 AND RIBOCICLIB |
2020 |
- Chen, Ying-Nan Pan
- Hao, Huaixiang
- Liu, Chen
- Mohseni, Morvarid
|
RU2813111C2 |
| PHARMACEUTICALLY ACCEPTABLE SALTS OF 2-{4-[(3S)-PIPERIDIN-3-YL]PHENYL}-2H-INDAZOLE-7-CARBOXAMIDE |
2009 |
- Fouli Dzhennifer R.
- Uilson Robert Darrin
|
RU2495035C2 |
| METHOD OF TREATING CANCER CARRYING EGFR MUTATIONS |
2007 |
|
RU2492864C2 |
| COMBINATION THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR TREATMENT OF CANCER |
2016 |
|
RU2786570C2 |
| COMBINED THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR CANCER TREATMENT |
2016 |
|
RU2752506C2 |
| METHOD OF TREATMENT BY APPLICATION OF COMBINED THERAPY |
2010 |
- Armstrong Robert K.
- Belli Barbara A.
|
RU2543348C2 |
| ANTINEOPLASTIC COMBINATIONS CONTAINING HKI-272 AND VINORELBINE |
2013 |
|
RU2670974C2 |
